Reach Us +1-947-333-4405


Trends In The Development Of Novel Approaches To Cure Benign Prostatic Hyperplasia: Hormones To 5α-Reeducates Inhibitors | 92079
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Google scholar citation report
Citations : 1147

Journal of Clinical & Experimental Pathology received 1147 citations as per google scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Trends in the development of novel approaches to cure benign prostatic hyperplasia: Hormones to 5α-Reeducates inhibitors

Joint Event on 6th World Congress and Expo on Breast Pathology and Cancer Diagnosis & 20th International Conference on Medicinal Chemistry and Rational Drugs

Neelima Dhingra

University Institute of Pharmaceutical Sciences, India

ScientificTracks Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681-C3-051

Benign prostatic hyperplasia (BPH) a common condition of aging men is characterized by nonmalignant enlargement of the prostate gland, and clinically manifested as lower urinary tract symptoms (LUTS). Past experience reveals that with the advent of profound knowledge of the pathogenesis, the natural history, and risk of the progression and new generation of experiments powered by technological breakthroughs, the concept of management has undergone many changes with time. The specific approach used to treat benign prostatic hyperplasia depends upon number of factors like age, prostrate size, weight, prostate specific antigen level and severity of the symptoms. Quest spanning over hundred years to find out the novel approaches for the potentially progressive condition (BPH) of aging men has resulted in the discovery of the Finasteride and Dutasteride as 5α-Reeducates Inhibitors in 2002, starting from the discovery of the first stillbesterol in the early 1937. Research outcome from our laboratories has also resulted in some novel steroidal derivatives as 5α-Reeducates Inhibitors and found to be more potent than Finasteride. These new agents can be used for the design of future targets and development of new drugs in the treatment of BPH. Yet one cannot be certain that the quest has ended and the discovery of this number of active leads may also help in developing new safe and effective drugs.

Neelima Dhingra is an academician by profession with 10 year of teaching and research experience. She earned her B. Pharmacy, M. Pharmacy (Pharmaceutical Chemistry), and Ph.D. (Pharmaceutical Chemistry) from the University Institute of Pharmaceutical Sciences, Panjab University, and Chandigarh. Presently, she is serving as an Assistant Professor at the Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Punjab University, and Chandigarh. Her major area of research focuses on Designing (2D-QSAR, 3D-QSAR), synthesis, spectroscopy analysis, physicochemical parameters and biological evaluation (in vitro, in vivo, in silico) of steroidal derivatives especially 5- alpha reeducates inhibitors. Research work has been credited with 2 US patents, 4 national patents, 40 abstracts, 22 research papers in the peer reviewed journals, 8 awards. She is a member on the editorial board of the various national journals and Editor Member of Asian Council of Scientific Editors 2014 onwards and also life member of various national scientific bodies like APTI, IPGA, PAS, PUPS, IABMS and SPER.

E-mail: [email protected]